Financials XP Chemistries AB

Equities

XPC

SE0016787279

Pharmaceuticals

Market Closed - Nasdaq Stockholm 09:30:00 02/07/2024 pm IST 5-day change 1st Jan Change
0.155 SEK +4.73% Intraday chart for XP Chemistries AB -13.41% +30.25%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 70.35 16.12 11.12
Enterprise Value (EV) 1 48.95 0.9184 3.29
P/E ratio -15.9 x -1.74 x -0.46 x
Yield - - -
Capitalization / Revenue 252 x 15.3 x 16.8 x
EV / Revenue 175 x 0.87 x 4.96 x
EV / EBITDA -9.88 x -0.11 x -0.38 x
EV / FCF - -1,12,862 x -4,24,471 x
FCF Yield - -0% -0%
Price to Book 2.31 x 0.55 x 0.43 x
Nbr of stocks (in thousands) 22,768 29,409 93,423
Reference price 2 3.090 0.5480 0.1190
Announcement Date 31/03/22 29/03/23 21/03/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales 1 0.2794 1.056 0.6637
EBITDA 1 -4.955 -8.503 -8.697
EBIT 1 -5.239 -9.858 -10.11
Operating Margin -1,875.05% -933.67% -1,522.75%
Earnings before Tax (EBT) 1 -5.711 -9.826 -9.976
Net income 1 -4.545 -7.917 -8.039
Net margin -1,626.8% -749.81% -1,211.26%
EPS 2 -0.1939 -0.3155 -0.2580
Free Cash Flow - -8.137 -7.752
FCF margin - -770.73% -1,167.97%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 31/03/22 29/03/23 21/03/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - - -
Net Cash position 1 21.4 15.2 7.83
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -8.14 -7.75
ROE (net income / shareholders' equity) - -26.2% -29.4%
ROA (Net income/ Total Assets) - -18.9% -21.8%
Assets 1 - 41.79 36.81
Book Value Per Share 2 1.340 0.9900 0.2700
Cash Flow per Share 2 0.9100 0.5200 0.0800
Capex 1 3 0.36 0.03
Capex / Sales 1,074.77% 34.04% 4.07%
Announcement Date 31/03/22 29/03/23 21/03/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. XPC Stock
  4. Financials XP Chemistries AB